The Fraunhofer Center for Nanoelectronic Technologies CNT in Dresden is an institution of the Fraunhofer-Gesellschaft created as a public-private partnership with industrial partners Infineon Technologies AG and Advanced Micro Devices AMD and other research partners. The new Center was established with the aim of rapidly transferring innovative, discrete process solutions for the fabrication of nanoelectronic systems on 300-mm wafers into the industrial manufacturing environment.
The Fraunhofer Institute for Ceramic Technologies and Systems covers the complete field of advanced ceramics, from basic research to applications. Services include the development and application of modern advanced ceramic materials, the development of industrial powder metallurgical technologies, and the manufacturing of prototypical components. Structural ceramics, functional ceramics and cermets are the main focus with emphasis on innovative complex systems which are applied in many industry sectors.
Starting from the know-how already available and the experience in classical robotics, sensor technology and development of very fast controllers, new drive systems and tools for precision positioning up to the nanometer range are developed.
Hybrid biological and synthetic particles have been developed which simulate the properties at the cell surfaces. On the surface of these cell-mimetic, i.e. cell-imitating, nanoparticles, membrane proteins are bound in such a way that their biological properties are fully maintained.
Main focus is the development of polymer systems for biomedical applications such as therapy, delivery or diagnostics. The lab studies a wide range of applied polymer systems including nanocarriers for drug delivery, copolymers for non-viral gene delivery and functional colloids for magnetic resonance imaging.
FriMat combines a leading fundamental research program on soft condensed matter and solid state physics with an innovative approach to synthesize novel compounds in order to create and study advanced materials. FriMat is determined to not only focus on the creation of novel materials and promote nanotechnology, but investigates into potential risks associated with nanoparticles, and develops new tools essential in any attempt to sample and characterize nanoparticles in the environment.
The Friedrich Miescher Institute is devoted to fundamental biomedical research. As part of the Novartis Research Foundation and one of the institutes of Novartis Corporate Research, the institute's goal is to exploit new technologies to further the understanding of the basic molecular mechanisms of cells and organisms in health and disease.
The Frontiers consortium is designed on five criteria: individual excellence in science, excellent nanotechnology infrastructure (clean room facilities), proven capability to initiate start-ups on the basis of new technology, outstanding relations with nanotechnology initiatives all over the world and, finally, a proven track record in cooperating with other members of the consortium. Frontiers consists of 192 scientists from 11 different research institutions scattered over Europe.
The objective of the society is to create an opportunity to provide information concerning basic science and applied technology relating to nano carbon based materials such as fullerenes, carbon nanotubes and graphene and to provide an opportunity for members to get together.
The objective of this EU project is the investigation and deliberate steering of supramolecular self-organization using complex molecules at well-defined substrates for the fabrication of functional nanostructures.
FUNFOX is a European Commission funded program which will demonstrate the capabilities of photonic crystals (PhC) to provide miniature and improved semiconductor optoelectronic devices needed in metropolitan core and access segments of optical networks.